How can corporate counsel proactively mitigate nuclear-verdict exposure?

What is actually driving nuclear-verdict frequency?

Three forces overlap. Frequency is up: Litigation Sentinel tracking recorded 149 nuclear verdicts of $10 million or more in 2025, totaling $25.1 billion, a 239 percent rise in frequency since 2020, when there were 44. Severity concentrates in products, auto and trucking, and medical malpractice, and it clusters in a handful of venues. The curve is real, and it is geographic, which is what makes it manageable.

In 2025, 33 of those verdicts crossed $100 million and 5 crossed a billion. The extremes get the headlines, but the manageable risk is the frequency underneath them: a rising count of eight and nine-figure awards, clustered in venues and case types you can name in advance.

Which levers can corporate counsel actually control?

Not the verdict. The inputs. You control which cases you fight and which you resolve, which counsel handles the hard ones, how fast a ripe case reaches settlement, and whether your defense rests on a documented record. Each attacks exposure before trial, where a nuclear number is still forming. The jury is the one variable you never get to set, so you manage every other one.

• Venue awareness: know which open matters sit in California, Florida, Texas, Georgia, and New York, where nuclear verdicts concentrate.
• Early resolution: flag settlement-ready cases while resolution is still cheap, before the demand outruns the record.
• Counsel selection: put your strongest firms on the hard cases in the hottest venues, measured on outcomes and difficulty.
• A documented record: defend from facts you tracked and acted on, not a file nobody has revisited since intake.

Does tort reform mitigate the risk on its own?

It helps, but you cannot wait on it. Florida's comprehensive 2023 reform moved it from the second-highest nuclear-verdict state to roughly tenth before counts partly rebounded. Georgia passed SB 68 in April 2025, restricting anchoring tactics in closing and requiring disclosure of medical damages. Reform tends to change frequency and mechanics, not eliminate large awards. Treat each reform as a reason to re-baseline a venue, not to assume the risk is gone.

Anchoring is the tactic reform keeps targeting for a reason: a large, unsupported number read to a jury pulls the award upward. Where a reform limits it, the mechanics of how damages get argued shift, but the venue does not become safe overnight. The proactive move is to instrument your own book by venue and re-baseline whenever the rules change, rather than assume a statute did the work for you.

How does seeing the case early actually lower nuclear exposure?

Because nuclear verdicts rarely start as nuclear. They escalate through cases that drifted: the specials doubled, the demand climbed, the reserve never moved. When you can see each matter from a current file, the ripe ones get resolved before the number compounds, and the dangerous ones get your best counsel early. Programs built on that visibility are architected around a 10% Targeted Defense Spend Reduction. Targeted, not guaranteed.

Read that number as program architecture, not a quote. It is a target a disciplined litigation program is designed to work toward when you can see the case from the file, never a promise. CaseGlide does not predict which case will go nuclear. It keeps every matter scored and current so the drifting ones surface while there is still time to act, and so oversight follows the venues and fact patterns where the tail is fattest.